Models to predict response to hormonal therapy in patients with recurrent or advanced endometrial cancer

被引：0

作者：

Jin, Xiaoman ^{[1
]}

Silvertand, Daphne ^{[1
]}

Werner, Henrica M. j. ^{[1
]}

Pijnenborg, Johanna M. a. ^{[2
]}

Lalisang, Roy I. ^{[1
]}

Bulten, Johan ^{[2
]}

Eriksson, Ane G. z. ^{[3
]}

Lindemann, Kristina ^{[3
]}

Van Beekhuizen, Heleen J. ^{[4
]}

Trum, Hans ^{[5
]}

Witteveen, Petronella. O. ^{[6
]}

Galaal, Khadra ^{[7
]}

Ginkel, Alexandra Van ^{[8
]}

Weinberger, Vit ^{[9
,10
]}

Sweegers, Sanne ^{[2
]}

Krakstad, Camilla ^{[11
]}

Van Weelden, Willem Jan ^{[2
]}

Fijten, Rianne ^{[12
]}

Romano, Andrea ^{[1
]}

NITEC Consortium ^{[13
]}

机构：

[1] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[2] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[3] Oslo Univ Hosp, Oslo, Norway

[4] Erasmus MC, Rotterdam, Netherlands

[5] Netherlands Canc Inst, Amsterdam, Netherlands

[6] Univ Med Ctr Utrecht, Utrecht, Netherlands

[7] Royal Cornwall Hosp NHS Trust, Truro, England

[8] Rijnstate Hosp, Arnhem, Netherlands

[9] Masaryk Univ, Brno, Czech Republic

[10] Univ Hosp Brno, Brno, Czech Republic

[11] Univ Bergen, Bergen, Norway

[12] MUMC, Maastricht, Netherlands

[13] Maastricht Univ, Maastricht, Netherlands

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期

关键词：

D O I：

10.1136/ijgc-2024-ESGO.318

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

266

引用

页码：A168 / A169

页数：2

共 50 条

[41] Progesterone Receptor Signaling in the Microenvironment of Endometrial Cancer Influences Its Response to Hormonal Therapy
Janzen, Deanna M.
Rosales, Miguel A.
Paik, Daniel Y.
Lee, Daniel S.
Smith, Daniel A.
Witte, Owen N.
Iruela-Arispe, M. Luisa
Memarzadeh, Sanaz
CANCER RESEARCH, 2013, 73 (15) : 4697 - 4710
[42] Systemic therapy for advanced or recurrent endometrial carcinoma.
Fleming G.F.
Current Oncology Reports, 1999, 1 (1) : 47 - 53
[43] Pelvic Exenterations for Advanced and Recurrent Endometrial Cancer: Clinical Outcomes of 40 Patients
Schmidt, Ana-Maria
Imesch, Patrick
Fink, Daniel
Egger, Herwig
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (04) : 716 - 721
[44] BRCA 1/2 Somatic Mutations in Patients with Advanced or Recurrent Endometrial Cancer
Fehniger, J.
Levine, D. A.
Pothuri, B.
GYNECOLOGIC ONCOLOGY, 2020, 158 (01) : E16 - E16
[45] Treatment patterns among patients with advanced/recurrent endometrial cancer in the United States
Liu, Jinan
Maiese, Eric M.
Emond, Bruno
Lafeuille, Marie-Helene
Lefebvre, Patrick
Ghelerter, Isabelle
Wu, Caterina
Hurteau, Jean
Thaker, Premal H.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
[46] Geographic disparities in prescribing patterns of molecularly targeted therapy in advanced and recurrent endometrial cancer
Lee, Grace
Evans, Elizabeth
Harsono, Alfonsus Adrian
Pothuri, Bhavana
Backes, Floor
Moore, Kathleen
Thaker, Premal
Jackson, Amanda
Wright, Jason
Ko, Emily
Konecny, Gottfried
Crafton, Sarah
Duska, Linda
Corr, Bradley
Castellano, Tara
Puechl, Allison
Bae-Jump, Victoria
Clements, Aine
Smitherman, Carson
Secord, Angeles Alvarez
Arend, Rebecca
GYNECOLOGIC ONCOLOGY, 2024, 190 : S349 - S350
[47] Do Not Forget about Hormonal Therapy for Recurrent Endometrial Cancer: A Review of Options, Updates, and New Combinations
Wagner, Vincent M.
Backes, Floor J.
CANCERS, 2023, 15 (06)
[48] CARBOPLATIN THERAPY IN ADVANCED ENDOMETRIAL CANCER
GREEN, JB
GREEN, S
ALBERTS, DS
OTOOLE, R
SURWIT, EA
NOLTIMIER, JW
OBSTETRICS AND GYNECOLOGY, 1990, 75 (04): : 696 - 700
[49] Systemic therapy for advanced endometrial cancer
Tazi, Youssef
Pautier, Patricia
Lhomme, Catherine
BULLETIN DU CANCER, 2012, 99 (01) : 93 - 97
[50] Systemic therapy for advanced endometrial cancer
Pautier, Patricia
Pommeret, Fanny
BULLETIN DU CANCER, 2017, 104 (12) : 1046 - 1053

← 1 2 3 4 5 →